Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
SRRA holding history
Sierra Oncology, Inc. in every 13F filed by Abingworth LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRRA overviewAll 13F holders of SRRAFull Q4 2022 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −1,314,127−100.0% | Sold out | Holders |
| Q2 2022 | 1,314,127 | $72.3M | 23.1% | +1150.0% | Added | Holders |
| Q1 2022 | 1,314,012 | $42.1M | 11.9% | +437,356+49.9% | Added | Holders |
| Q4 2021 | 876,656 | $19.1M | 4.6% | 00.0% | Unchanged | Holders |
| Q3 2021 | 876,656 | $19.0M | 4.3% | +5,531+0.6% | Added | Holders |
| Q2 2021 | 871,125 | $16.8M | 5.2% | 00.0% | Unchanged | Holders |
| Q1 2021 | 871,125 | $14.7M | 5.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.